Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$317M |
| 2 |
Walmart Inc
WMT
|
+$218M |
| 3 |
Linde
LIN
|
+$174M |
| 4 |
PayPal
PYPL
|
+$133M |
| 5 |
Union Pacific
UNP
|
+$126M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$724M |
| 2 |
Uber
UBER
|
+$527M |
| 3 |
ExxonMobil
XOM
|
+$450M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$365M |
| 5 |
Apple
AAPL
|
+$336M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.8% |
| 2 | Healthcare | 17.12% |
| 3 | Consumer Discretionary | 13.21% |
| 4 | Financials | 8.81% |
| 5 | Consumer Staples | 7.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3101
EVI Industries
EVI
$181M
| $289K | ﹤0.01% |
11,597
+432
| +4% | +$9.49K |
|
|
IOBT
3102
DELISTED
IO Biotech
IOBT
| $289K | ﹤0.01% |
167,200
+78,300
| +88% | +$136K |
|
3103
Ondas Inc
ONDS
$4.27B
| $289K | ﹤0.01% |
+298,199
| New | +$392K |
|
3104
Mannatech
MTEX
$9.24M
| $288K | ﹤0.01% |
35,078
-721
| -2% | -$6.4K |
|
3105
Ranpak Holdings
PACK
$439M
| $288K | ﹤0.01% |
+36,600
| New | +$192K |
|
|
SDPI
3106
DELISTED
Superior Drilling Products Inc.
SDPI
| $288K | ﹤0.01% |
314,994
-66,816
| -17% | -$52.1K |
|
|
FAT
3107
DELISTED
FAT Brands
FAT
| $287K | ﹤0.01% |
67,813
+8,075
| +14% | +$35K |
|
|
SWKH
3108
DELISTED
SWK Holdings
SWKH
| $287K | ﹤0.01% |
20,823
+126
| +0.6% | +$1.7K |
|
3109
Data Storage Corp
DTST
$7.13M
| $286K | ﹤0.01% |
50,000
-34,506
| -41% | -$150K |
|
3110
Smartbird Inc
BIRD
$19.5M
| $283K | ﹤0.01% |
20,365
+1,845
| +10% | +$34.4K |
|
3111
Cognition Therapeutics
CGTX
$79.6M
| $283K | ﹤0.01% |
155,700
+143,700
| +1,198% | +$297K |
|
3112
abrdn Bloomberg All Commodity Strategy K-1 Free ETF
BCI
$2.95B
| $282K | ﹤0.01% |
+14,282
| New | +$276K |
|
3113
Codere Online
CDRO
$417M
| $280K | ﹤0.01% |
40,200
+18,000
| +81% | +$94.1K |
|
|
ZENV
3114
DELISTED
Zenvia
ZENV
| $280K | ﹤0.01% |
105,160
-16,040
| -13% | -$27.2K |
|
3115
Franklin FTSE Japan ETF
FLJP
$3.97B
| $279K | ﹤0.01% |
9,000
-64,700
| -88% | -$1.91M |
|
|
SBFM
3116
Sunshine Biopharma
SBFM
$2.78M
| $279K | ﹤0.01% |
231
+228
| +7,600% | +$670K |
|
3117
State Street SPDR S&P Semiconductor ETF
XSD
$2.72B
| $279K | ﹤0.01% |
+1,200
| New | +$265K |
|
3118
Fidelity MSCI Real Estate Index ETF
FREL
$1.5B
| $277K | ﹤0.01% |
+10,600
| New | +$273K |
|
3119
Smith Douglas Homes
SDHC
$124M
| $276K | ﹤0.01% |
+9,300
| New | +$261K |
|
3120
First Internet Bancorp
INBK
$257M
| $274K | ﹤0.01% |
7,900
-1,419
| -15% | -$42.9K |
|
3121
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
$18.2B
| $272K | ﹤0.01% |
5,100
-18,100
| -78% | -$900K |
|
|
IRD
3122
Opus Genetics
IRD
$306M
| $272K | ﹤0.01% |
135,300
+111,075
| +459% | +$282K |
|
3123
a.k.a. Brands
AKA
$124M
| $271K | ﹤0.01% |
27,269
+5,175
| +23% | +$52.3K |
|
3124
Auburn National Bancorp
AUBN
$91.3M
| $271K | ﹤0.01% |
14,041
+1,400
| +11% | +$28.7K |
|
3125
Traws Pharma
TRAW
$6.85M
| $271K | ﹤0.01% |
10,728
+2,774
| +35% | +$53.5K |
|
Similar funds
Renaissance Technologies's Q1 2024 Portfolio in Review
As of Q1 2024, Renaissance Technologies held 4,246 positions worth $63.6B, down 1.5% from $64.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $5.25B in Q1 2024, closing 582 positions and reducing 1,517 holdings. Its most notable exit was ExxonMobil, an estimated $450M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Chevron worth $331M.
- Renaissance Technologies's largest Q1 2024 buy was Chevron: 2,097,623 shares worth $331M.
- Renaissance Technologies added most to Walmart Inc in Q1 2024, an estimated $218M increase.
- Renaissance Technologies's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $724M.
- Renaissance Technologies fully exited ExxonMobil in Q1 2024, selling an estimated $450M.
- Renaissance Technologies's ten largest holdings make up 12% of its $63.6B portfolio in Q1 2024.
- Renaissance Technologies opened 563 new positions and closed 582 in Q1 2024.
- Renaissance Technologies's portfolio value fell 1.5% quarter-over-quarter to $63.6B.
Based on Renaissance Technologies's 13F filing for Q1 2024, filed 13 May 2024.